Guido Gembillo

1.4k total citations
56 papers, 753 citations indexed

About

Guido Gembillo is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Guido Gembillo has authored 56 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Nephrology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Guido Gembillo's work include Chronic Kidney Disease and Diabetes (10 papers), Renal Diseases and Glomerulopathies (9 papers) and Parathyroid Disorders and Treatments (6 papers). Guido Gembillo is often cited by papers focused on Chronic Kidney Disease and Diabetes (10 papers), Renal Diseases and Glomerulopathies (9 papers) and Parathyroid Disorders and Treatments (6 papers). Guido Gembillo collaborates with scholars based in Italy, United States and France. Guido Gembillo's co-authors include Domenico Santoro, Rossella Siligato, Valeria Cernaro, Michele Buemi, Davide Bolignano, Giovanni Conti, Graziella D’Arrigo, Alfio Edoardo Giuffrida, Vincenzo Calabrese and Luca Visconti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Guido Gembillo

44 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Gembillo Italy 16 294 150 144 113 96 56 753
Αnila Duni Greece 12 216 0.7× 89 0.6× 125 0.9× 94 0.8× 71 0.7× 31 632
Ziad A. Massy France 18 498 1.7× 88 0.6× 129 0.9× 114 1.0× 178 1.9× 39 928
Athanasios Roumeliotis Greece 14 293 1.0× 74 0.5× 66 0.5× 86 0.8× 97 1.0× 41 572
Shanyan Lin China 16 351 1.2× 138 0.9× 198 1.4× 84 0.7× 47 0.5× 40 814
Jenny E. Kootstra‐Ros Netherlands 17 123 0.4× 133 0.9× 90 0.6× 93 0.8× 117 1.2× 42 833
Won Suk An South Korea 18 346 1.2× 88 0.6× 132 0.9× 64 0.6× 234 2.4× 68 856
Kausik Umanath United States 14 655 2.2× 298 2.0× 301 2.1× 164 1.5× 95 1.0× 27 1.4k
Shih-Ping Hsu Taiwan 13 201 0.7× 49 0.3× 94 0.7× 122 1.1× 52 0.5× 16 710
Guo Bao Wang China 8 445 1.5× 210 1.4× 208 1.4× 351 3.1× 112 1.2× 8 1.2k
Stylianos Panagoutsos Greece 14 254 0.9× 67 0.4× 72 0.5× 129 1.1× 62 0.6× 49 544

Countries citing papers authored by Guido Gembillo

Since Specialization
Citations

This map shows the geographic impact of Guido Gembillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Gembillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Gembillo more than expected).

Fields of papers citing papers by Guido Gembillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Gembillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Gembillo. The network helps show where Guido Gembillo may publish in the future.

Co-authorship network of co-authors of Guido Gembillo

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Gembillo. A scholar is included among the top collaborators of Guido Gembillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Gembillo. Guido Gembillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Calabrese, Vincenzo, Roberta Messina, Valeria Cernaro, et al.. (2025). Hypercalcemia: A Practice Overview of Its Diagnosis and Causes. SHILAP Revista de lepidopterología. 5(1). 7–7.
3.
Gembillo, Guido, Luca Zanoli, Antonino Catalano, et al.. (2025). Fracture Risk in Chronic Kidney Disease: Addressing an Overlooked Complication. Metabolites. 15(7). 460–460. 1 indexed citations
4.
Gembillo, Guido, et al.. (2025). Cryptococcosis in Pediatric Renal Transplant Recipients: Comparative Insights from Adult Cases. Medicina. 61(6). 1108–1108.
5.
Catalano, Antonino, Giovanni Squadrito, Agostino Gaudio, et al.. (2024). Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study. Journal of Clinical Medicine. 13(20). 6239–6239. 5 indexed citations
6.
7.
Metro, Daniela, Francesco Corallo, Guido Gembillo, et al.. (2024). What about the Use of Ice Cream as a Supplementary Diet in Chronic Kidney Disease? A Case–Control Study. SHILAP Revista de lepidopterología. 12(2). 22–22. 1 indexed citations
8.
Gembillo, Guido, et al.. (2024). Investigational new drugs for the treatment of chronic renal failure: an overview of the literature. Expert Opinion on Investigational Drugs. 33(4). 319–334. 4 indexed citations
9.
Conti, Giovanni, et al.. (2023). How to Choose the Right Treatment for Membranous Nephropathy. Medicina. 59(11). 1997–1997. 4 indexed citations
10.
Cernaro, Valeria, Guido Gembillo, Francesco Figura, et al.. (2023). Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers. 15(6). 1891–1891. 8 indexed citations
11.
Santoro, Domenico, Guido Bellinghieri, Vincenzo Savica, & Guido Gembillo. (2023). Franz Volhard: 150th Birth Anniversary of a Father of Nephrology and Hypertension. Experimental and Clinical Transplantation. 21(Suppl 2). 38–41.
12.
Gembillo, Guido, Luca Visconti, Alfio Edoardo Giuffrida, et al.. (2022). Role of Zinc in Diabetic Kidney Disease. Nutrients. 14(7). 1353–1353. 33 indexed citations
13.
Cernaro, Valeria, Vincenzo Calabrese, Saverio Loddo, et al.. (2022). Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients. International Urology and Nephrology. 54(9). 2355–2364. 7 indexed citations
14.
Gembillo, Guido, et al.. (2021). The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies. Medicina. 57(9). 868–868. 26 indexed citations
15.
Siligato, Rossella, Guido Gembillo, Vincenzo Calabrese, Giovanni Conti, & Domenico Santoro. (2021). Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever. Medicina. 57(10). 1049–1049. 22 indexed citations
16.
Pattharanitima, Pattharawin, Charat Thongprayoon, Wisit Kaewput, et al.. (2021). Machine Learning Prediction Models for Mortality in Intensive Care Unit Patients with Lactic Acidosis. Journal of Clinical Medicine. 10(21). 5021–5021. 11 indexed citations
17.
Gembillo, Guido, et al.. (2021). Vitamin D and Glomerulonephritis. Medicina. 57(2). 186–186. 29 indexed citations
18.
Santoro, Domenico, Massimo Torreggiani, Valeria Cernaro, et al.. (2021). Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives. International Journal of Molecular Sciences. 22(11). 5425–5425. 34 indexed citations
19.
Pisano, Anna, Valeria Cernaro, Guido Gembillo, et al.. (2017). Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 18(11). 2283–2283. 46 indexed citations
20.
Bolignano, Davide, Valeria Cernaro, Guido Gembillo, et al.. (2017). Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis. PLoS ONE. 12(6). e0178699–e0178699. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Αnila Duni Breakdown of academic impact, for papers by Ziad A. Massy Breakdown of academic impact, for papers by Athanasios Roumeliotis Breakdown of academic impact, for papers by Shanyan Lin Breakdown of academic impact, for papers by Jenny E. Kootstra‐Ros Breakdown of academic impact, for papers by Won Suk An Breakdown of academic impact, for papers by Kausik Umanath Breakdown of academic impact, for papers by Shih-Ping Hsu Breakdown of academic impact, for papers by Guo Bao Wang Breakdown of academic impact, for papers by Stylianos Panagoutsos
Rankless by CCL
2026